Glomeria Therapeutics logo — company profile

Glomeria Therapeutics

Founded 2010 Italy Italy 4 employees Grant Total: $3.84M Biotechnology, Health Care +3

General Information

Company Name Glomeria Therapeutics
Founded Year 2010
Location Italy Italy
Founders / Decision Makers
Team member
Employees 4
Industries Biotechnology, Health Care, Internet +2
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Glomeria Therapeutics. To contact Glomeria Therapeutics, visit glomeria.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Glomeria Therapeutics

Glomeria Therapeutics is an Italian biotech startup founded in 2010. Specializing in research and development, the company focuses on delivering hospital products, drugs, and medical therapy devices to patients with severe nephropathy and cardiopathy. With a strong emphasis on minimizing infrastructure costs and maximizing access to scientific knowledge, Glomeria conducts all creative and development phases in-house while outsourcing industrial development to specialized service firms. The company boasts a highly qualified management team and scientific board with extensive experience in pharmaceutical products and medical devices. Its last investment of €2.84M came from Sofimac Investment Managers and EASME - EU Executive Agency for SMEs on 01 October 2016.

Taxonomy: Biomedical Research, Nephrology, Cardiology, Pharmaceutical Development, Peritoneal Dialysis, Healthcare Innovation, Research and Development, Medical Therapy, Hospital Products, Medical Technology, Scientific Knowledge, Healthcare Industry, Innovation Management

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €2.84M 2
Sofimac Investment Managers, EASME - EU Executive Agency for SMEs
01 Oct 2016
Venture Round €1.00M 3
Vertis, Green Arrow Capital +1
19 Sep 2015
Seed Round Undisclosed 1
Vertis
01 Apr 2010

Glomeria Therapeutics Alternatives & Competitors

View All Alternatives
Glomeria Therapeutics vs
Byonyks
Byonyks United States

Bloodless Dialysis

Convertible Note
76 employees
Health Care, Medical Devices
Glomeria Therapeutics vs

Renewing Renal Care

Debt Financing
14 employees
Biotechnology, Health Care
Glomeria Therapeutics vs

To Give More Chance to Life

30 employees
Biotechnology, Health Care

FAQ About Glomeria Therapeutics

Glomeria Therapeutics is a company specialized in research and development. Our mission is to deliver hospital products, drugs and medical therapy devices to patients with severe forms of nephropathy and cardiopathy. It is Glomeria Therapeutics’ policy to keep infrastructure costs to a minimu...
Glomeria Therapeutics was founded in 2010.
Glomeria Therapeutics is headquartered in Italy.
Glomeria Therapeutics operates in Biotechnology, Health Care, Internet, Medical Devices and Social Media. Its work centres on Biomedical Research, Nephrology, Cardiology and Pharmaceutical Development.
Glomeria Therapeutics has approximately 4 employees.
Glomeria Therapeutics has completed 3 funding rounds, raising a total of $3.84M. The latest funding stage is Grant.
Top alternatives and competitors to Glomeria Therapeutics include Byonyks, Opterion Health AG, Aferetica S.r.l., PrecisemAb Biotech Co., Ltd., DrugBank. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Glomeria Therapeutics and Byonyks are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Glomeria Therapeutics, https://bouncewatch.com/company/glomeria-therapeutics, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes